METTL5 and cardiac hypertrophy: As a result, the expression level of METTL5 was reduced in Calcineurin transgenic (CnA-Tg) hearts but remained unaltered in transverse aortic binding (TAC)-induced cardiac hypertrophy (Figure 1B).